Accelerating Clinical Trial Startup with Latest goBalto Activate Release

Industry leader in clinical study startup adds robust team management and submission planning features

SAN FRANCISCO, Oct. 6, 2015 /PRNewswire/ -- goBalto, Inc., the leading provider of cloud-based clinical study startup solutions, announced today its latest version of goBalto Activate. The third major release of 2015 offers new features that further accelerate clinical study startup.

 
"Expedited programs, such as 21st Century Cures Act, compassionate use and "Right to Try" laws, and the recent calls for greater transparency in clinical trial results, are a manifestation of the public's dissatisfaction with the clinical trials process, which has been slow to adopt new innovative technologies, technologies which have the ability to significantly reduce cycle times and get much-needed therapies to those in need faster," said Sujay Jadhav, goBalto's CEO.

According to Jeff Kasher, formerly VP Clinical Innovation and Implementation, Eli Lilly and Company, and now president of Patients Can't Wait and advisor to goBalto, "Patients across the globe are waiting for new therapies, but complicated study protocols, globalization, and paper-based methods of conducting trials continue to delay market entry. Current thinking looks to an improved study startup process as holding great promise for accelerating clinical trials."

Activate customers report improved business performance and a reduction in cycle times by 30-plus percent. With more than 2,000 pharmaceutical and CRO users in more than 60 countries using Activate to manage, track, and complete study startup tasks, goBalto has the largest industry-proven set of country workflows. Standard 'out-of-the-box' country specific regulatory business process workflows allow quick site activation, leading to greater cost savings and faster market entry, making valuable therapies available to patients sooner.

"We are committed to providing our customers with cutting edge functionality, which has been proven to accelerate the clinical trial process," said Jadhav. "We now service three of the top five CROs and more than two-thirds of the top 20 pharmaceutical companies, managing their clinical trial documents globally."

New capabilities just released aim to improve administrative tasks, with a focus on account provisioning and team member management, submission planning, and document handling.

About goBalto

goBalto develops next-generation solutions that simplify and accelerate clinical study startup in the pharmaceutical, biotechnology, and medical device industries. Our management team has over 100 years of combined experience in the life sciences industry and enterprise software implementation. Our team has worked for such companies as Amgen, Genentech, Quintiles, Roche, Johnson & Johnson, and Model N. With a proven commitment to customer success, disruption, and study startup optimization, we're changing the way our leading global pharma and CRO customers approach their business processes. Based in San Francisco, California, we have satellite offices in Pennsylvania and Singapore. For more information, visit www.gobalto.com.

Press contact:
Craig Morgan
415.671.4372
cmorgan@gobalto.com